16-56192353-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_020988.3(GNAO1):c.118G>T(p.Gly40Trp) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 15/24 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G40R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_020988.3 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020988.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GNAO1 | NM_020988.3 | MANE Select | c.118G>T | p.Gly40Trp | missense splice_region | Exon 1 of 9 | NP_066268.1 | ||
| GNAO1 | NM_138736.3 | c.118G>T | p.Gly40Trp | missense splice_region | Exon 1 of 8 | NP_620073.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GNAO1 | ENST00000262493.12 | TSL:1 MANE Select | c.118G>T | p.Gly40Trp | missense splice_region | Exon 1 of 9 | ENSP00000262493.6 | ||
| GNAO1 | ENST00000262494.13 | TSL:1 | c.118G>T | p.Gly40Trp | missense splice_region | Exon 1 of 8 | ENSP00000262494.7 | ||
| GNAO1 | ENST00000638705.1 | TSL:1 | c.118G>T | p.Gly40Trp | missense splice_region | Exon 1 of 8 | ENSP00000491223.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1396332Hom.: 0 Cov.: 25 AF XY: 0.00 AC XY: 0AN XY: 698062
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This sequence change replaces glycine with tryptophan at codon 40 of the GNAO1 protein (p.Gly40Trp). The glycine residue is highly conserved and there is a large physicochemical difference between glycine and tryptophan. This variant also falls at the last nucleotide of exon 1 of the GNAO1 coding sequence, which is part of the consensus splice site for this exon. This variant is not present in population databases (ExAC no frequency). This variant has been observed to be de novo in an individual with early onset epilepsy (PMID: 29390993). ClinVar contains an entry for this variant (Variation ID: 280526). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. Different variants affecting this nucleotide (c.118G>C, c.118G>A) have been determined to be pathogenic (PMID: 26485252, 28357411, 28817111). This suggests that this nucleotide is important for normal RNA splicing, and that other variants at this position may also be pathogenic.
not provided Pathogenic:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30682224, 32695065, 28357411, 26485252, 28817111, 33057194, 35982159, 31440721, 29390993)
Developmental and epileptic encephalopathy, 17 Other:1
Variant classified as Pathogenic and reported on 09-03-2021 by DLE Laboratory https://www.dle.com.br/o-que-fazemos/. GenomeConnect-GNAO1 assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at